Medicines for pregnancy-specific conditions
Concept Foundation identified a need to accelerate the development of new innovations for pregnancy-specific conditions as a priority, supported by grant funding from the Bill & Melinda Gates Foundation.
Concept Foundation presents a brief background and introduction as to why this is a current priority and the particular research priorities and challenges for different conditions. The report also points to some possible solutions that have been provided through interviews and discussions with a diverse group of stakeholders in the field.
This report is complemented by the comprehensive pipeline analysis conducted by Policy Cures Research (PCR) as part of the AIM project.
WHY DO WE NEED A R&D BLUEPRINT?
We believe that the maternal health field is complex and when priorities are identified at the global health and development level, R&D is still not seen as a priority.
We need an R&D blueprint now because sufficient new knowledge has accumulated for the development of new solutions for key pregnancy-specific conditions.